HK1138376A1 - Clinical intervention directed diagnostic methods - Google Patents

Clinical intervention directed diagnostic methods

Info

Publication number
HK1138376A1
HK1138376A1 HK10105141.5A HK10105141A HK1138376A1 HK 1138376 A1 HK1138376 A1 HK 1138376A1 HK 10105141 A HK10105141 A HK 10105141A HK 1138376 A1 HK1138376 A1 HK 1138376A1
Authority
HK
Hong Kong
Prior art keywords
diagnostic methods
clinical intervention
intervention directed
directed diagnostic
clinical
Prior art date
Application number
HK10105141.5A
Other languages
English (en)
Chinese (zh)
Inventor
Anthony P Shuber
Eugene Chiu
Original Assignee
Physicians Choice Lab Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/840,777 external-priority patent/US20090047694A1/en
Application filed by Physicians Choice Lab Services Llc filed Critical Physicians Choice Lab Services Llc
Publication of HK1138376A1 publication Critical patent/HK1138376A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
HK10105141.5A 2007-02-23 2010-05-26 Clinical intervention directed diagnostic methods HK1138376A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90303807P 2007-02-23 2007-02-23
US11/840,777 US20090047694A1 (en) 2007-08-17 2007-08-17 Clinical Intervention Directed Diagnostic Methods
PCT/US2008/054563 WO2008103815A2 (en) 2007-02-23 2008-02-21 Clinical intervention directed diagnostic methods

Publications (1)

Publication Number Publication Date
HK1138376A1 true HK1138376A1 (en) 2010-08-20

Family

ID=39710742

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10105141.5A HK1138376A1 (en) 2007-02-23 2010-05-26 Clinical intervention directed diagnostic methods

Country Status (6)

Country Link
EP (1) EP2126562B1 (ja)
JP (1) JP2010519529A (ja)
CA (1) CA2679205A1 (ja)
ES (1) ES2530209T3 (ja)
HK (1) HK1138376A1 (ja)
WO (1) WO2008103815A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8431367B2 (en) 2007-09-14 2013-04-30 Predictive Biosciences Corporation Detection of nucleic acids and proteins
US8852893B2 (en) 2007-09-14 2014-10-07 Physicians Choice Laboratory Services, Llc Detection of nucleic acids and proteins
US7955822B2 (en) 2007-09-14 2011-06-07 Predictive Biosciences Corp. Detection of nucleic acids and proteins
US8563235B2 (en) * 2009-11-06 2013-10-22 National University Corporation Chiba University Biomarkers of biliary tract cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1997014037A1 (en) * 1995-10-12 1997-04-17 Chiron Diagnostics Corporation Determination and monitoring of bladder cancer
US7374886B2 (en) * 1999-04-09 2008-05-20 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
ES2244417T3 (es) * 1999-04-09 2005-12-16 Rigshospitalet Inhibidor de tejido de metaloproteasa de matriz tipo-1 (timp-1) como un marcador de cancer.
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
WO2005013804A2 (en) * 2003-08-05 2005-02-17 Euro-Celtique S.A. ErbB RECEPTOR METHODS AND KITS FOR MONITORING CHEMOTHERAPY RESISTANCE
CA2558808A1 (en) * 2004-03-05 2005-09-22 Rosetta Inpharmatics Llc Classification of breast cancer patients using a combination of clinical criteria and informative genesets
DK1831699T3 (da) * 2004-12-20 2010-03-15 Antibodyshop As Bestemmelse af neutrofil gelatine-associeret lipocalin (NGAL) som en diagnostisk markør for nyresygdomme
DE602006018578D1 (de) * 2005-01-28 2011-01-13 Childrens Medical Center Diagnose- und prognoseverfahren von blasenkrebs.
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods

Also Published As

Publication number Publication date
EP2126562A4 (en) 2011-08-10
EP2126562B1 (en) 2014-12-31
WO2008103815A2 (en) 2008-08-28
EP2126562A2 (en) 2009-12-02
CA2679205A1 (en) 2008-08-28
ES2530209T3 (es) 2015-02-27
WO2008103815A3 (en) 2008-10-09
JP2010519529A (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
EP2144166A4 (en) DIAGNOSTIC SYSTEM
EP2128592A4 (en) DIAGNOSTIC EQUIPMENT
PT2029220E (pt) Sonda médica
EP2196137A4 (en) MEDICAL DIAGNOSTIC SUPPORT SYSTEM
EP2024512A4 (en) METHODS FOR THE DIAGNOSIS OF ABNORMAL F CHARACTERS
EP2086400A4 (en) IMPROVED MEDICAL DIAGNOSTIC DEVICE
EP2391971A4 (en) NON-INVASIVE DIAGNOSTIC SYSTEM
EP2235536A4 (en) HER-2 DIAGNOSTIC METHODS
GB0716885D0 (en) Diagnostic agent
GB0814419D0 (en) Blood analysis
GB0922006D0 (en) Diagnostic
PL2005182T3 (pl) Kliniczne korelaty
PL2245463T3 (pl) Sposób diagnozowania
EP2304437A4 (en) DIAGNOSTIC AID SPECIFIC TO A DISEASE
IL199807A (en) Biometric diagnosis
IL210424A0 (en) Diagnostic snps for cardiac diseases
HK1138376A1 (en) Clinical intervention directed diagnostic methods
EP2222689A4 (en) THERAPEUTIC AND DIAGNOSTIC COMPOUNDS
EP2126564A4 (en) DIAGNOSTIC PROCEDURE
GB0718748D0 (en) Diagnostic method
GB0803833D0 (en) Diagnostic methods
GB0812414D0 (en) Diagnostic methods
GB0700551D0 (en) Diagnostic method
GB0621369D0 (en) Diagnostic
GB0611923D0 (en) Diagnostic

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190221